Interpace Diagnostics (IDXG) Reports Q4 EPS of $3.24

Interpace Diagnostics (NASDAQ: IDXG) reported Q4 EPS of $3.24, versus ($4.59) reported last year. Revenue for the quarter came in at $3.1 thousand, versus $13.09 thousand reported last year.

For earnings history and earnings-related data on Interpace Diagnostics (IDXG) click here.

You May Also Be Interested In

• Lucid reports Q2 output, names new CFO and five other leaders
• General Mills (GIS) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 EPS Guidance
• Isabella Bank added to Russell 2000 index after Nasdaq listing